Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the Australian biotech to point to the anti-infective's potential to counter ...

Recce awarded expedited regulatory review status in Indonesia to fast-track progression of trial Company on track to start trial this quarter Special Report: Recce Pharmaceuticals has received ...